Suchen
Monte Rosa Therapeutics Inc
GLUEZur Watchlist hinzufügen
16.520USD
-6.160-27.16%
Handelsschluss 07-31 16:00（ET）Kurse um 15 Minuten verzögert
1.40BMarktkapitalisierung
VerlustKGV TTM
Aktionärsstatistik
Aktualisiert: Sun, May 10
Aktualisiert: Sun, May 10
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
New Enterprise Associates (NEA)
9.11%
Dimension Management, L.P.
7.71%
T. Rowe Price Associates, Inc.
5.94%
TCG Crossover Management, LLC
5.47%
Baker Bros. Advisors LP
5.14%
Andere
66.62%
Aktionäre
Aktionäre
Anteil
New Enterprise Associates (NEA)
9.11%
Dimension Management, L.P.
7.71%
T. Rowe Price Associates, Inc.
5.94%
TCG Crossover Management, LLC
5.47%
Baker Bros. Advisors LP
5.14%
Andere
66.62%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
29.94%
Venture Capital
21.43%
Hedge Fund
17.28%
Investment Advisor/Hedge Fund
15.68%
Research Firm
1.65%
Individual Investor
0.70%
Pension Fund
0.19%
Bank and Trust
0.16%
Family Office
0.11%
Andere
12.87%
Institutionelle Beteiligung
Aktualisiert: Wed, Apr 1
Aktualisiert: Wed, Apr 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2026Q1
308
72.05M
85.28%
-1.77M
2025Q4
256
70.11M
96.98%
+1.10M
2025Q3
233
66.43M
102.01%
+1.24M
2025Q2
232
62.74M
101.99%
-2.45M
2025Q1
235
60.82M
98.88%
-7.09M
2024Q4
220
61.73M
100.63%
-766.83K
2024Q3
200
57.64M
94.07%
-4.29M
2024Q2
191
55.42M
93.92%
+8.23M
2024Q1
185
49.41M
98.58%
+2.43M
2023Q4
187
49.83M
99.64%
+961.54K
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
New Enterprise Associates (NEA)
7.69M
9.61%
--
--
Mar 17, 2026
Dimension Management, L.P.
5.66M
7.08%
+905.70K
+19.04%
Dec 31, 2025
T. Rowe Price Associates, Inc.
5.02M
6.28%
+476.43K
+10.48%
Dec 31, 2025
TCG Crossover Management, LLC
4.62M
5.78%
+194.45K
+4.39%
Dec 31, 2025
Baker Bros. Advisors LP
4.35M
5.43%
-570.36K
-11.60%
Dec 31, 2025
BVF Partners L.P.
3.84M
4.79%
-1.82M
-32.23%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
3.64M
4.54%
+334.35K
+10.13%
Dec 31, 2025
Suvretta Capital Management, LLC
3.36M
4.2%
--
--
Dec 31, 2025
Versant Ventures
3.25M
4.06%
-1.13M
-25.84%
Jan 08, 2026
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
Virtus LifeSci Biotech Clinical Trials ETF
1.77%
Royce Quant Small-Cap Quality Value ETF
0.47%
iShares Micro-Cap ETF
0.12%
ProShares Ultra Nasdaq Biotechnology
0.12%
Avantis US Small Cap Equity ETF
0.08%
Invesco Nasdaq Biotechnology ETF
0.08%
iShares Russell 2000 Value ETF
0.05%
iShares Biotechnology ETF
0.05%
Invesco RAFI US 1500 Small-Mid ETF
0.04%
ProShares Hedge Replication ETF
0.03%
Mehr Anzeigen
Virtus LifeSci Biotech Clinical Trials ETF
Anteil1.77%
Royce Quant Small-Cap Quality Value ETF
Anteil0.47%
iShares Micro-Cap ETF
Anteil0.12%
ProShares Ultra Nasdaq Biotechnology
Anteil0.12%
Avantis US Small Cap Equity ETF
Anteil0.08%
Invesco Nasdaq Biotechnology ETF
Anteil0.08%
iShares Russell 2000 Value ETF
Anteil0.05%
iShares Biotechnology ETF
Anteil0.05%
Invesco RAFI US 1500 Small-Mid ETF
Anteil0.04%
ProShares Hedge Replication ETF
Anteil0.03%